Clinical Trials List
2025-12-01 - 2028-06-30
Phase III
Recruiting3
-
Trial Applicant
IQVIA RDS Taiwan Ltd.
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/08/01
Investigators and Locations
Co-Principal Investigator
- Chon-Haw Tsai Division of Neurology
- Chung-Hsiang Liu Division of Neurology
- Wei-Shih Huang Division of Neurology
- Yuh-Cherng Guo Division of Neurology
- Yi-Ting Hsu Division of Neurology
- Hui-Chun Huang Division of Neurology
- Kuan-Fei Chen Division of Neurology
- Jui-Cheng Chen Division of Neurology
- Yi-Chien Yang Division of Neurology
- Hung-Yu Huang Division of Neurology
- Fu-Yu Lin Division of Neurology
- Ching-Hua Lu Lu Division of Neurology
- Sheng-Ta Tsai Division of Neurology
- Yu Ao Division of Neurology
- Wei-Chung Wang Division of Neurology
- 黃上芝 Division of Neurology
- 林欽揚 Division of Neurology
- 張芳慈 Division of Neurology
- 張育嘉 Division of Neurology
- 許乾盛 Division of Neurology
- 黃詩潔 Division of Neurology
Co-Principal Investigator
- Jiann-Shing Jeng Division of Neurology
- LI-KAI TSAI Division of Neurology
- SHIN-JOE YEH Division of Neurology
- 李崇維 Division of Radiology
- YEN-HENG LIN Division of Radiology
- CHIH-HAO CHEN Division of Neurology
Co-Principal Investigator
- 吳俊毅 Division of Emergency Medicine
- 陳耀亮 Division of Radiology
- 翁偉捷 Division of Neurology
- 蘇豐傑 Division of Neurology
- 魏怡嘉 Division of Neurology
- 林舜文 Division of Neurology
- 李景行 Division of Emergency Medicine
- 李光永 Division of Neurology
- 趙中豪 Division of Neurology
- 林語立 Division of Neurology
- 陳奕翔 Division of Neurology
Co-Principal Investigator
- 楊宗翰 Division of Radiology
- 許立奇 Division of Neurology
- 李怡慧 Division of Neurology
- Nai-Fang Chi Division of Neurology
- 林浚仁 Division of Neurology
- Hung-Yu Liu Division of Neurology
Co-Principal Investigator
- 陳嘉泓 Division of Neurology
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
83 participants
-
Global
1325 participants